Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, October 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 78 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan

Article in Journal of Pharmaceutical Policy and Practice (April 2024)

Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country

Article in Frontiers in Pharmacology (September 2022)

Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan

Article in Frontiers in Pharmacology (May 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.